Kristina Gervin

Oslo University Hospital

Papers

1

Total Citations

20

H-Index

1

About

Kristina Gervin is a leading researcher in human genetics and epigenomics, with a particular focus on the molecular underpinnings of connective tissue disorders and the role of epigenetic variation in human health and disease. Her early, highly cited work established a rapid and efficient sequencing strategy for detecting mutations in the *FBN1* gene, the primary cause of Marfan syndrome and related type-1 fibrillinopathies. This contribution, which has garnered over 20 citations, addressed a major diagnostic challenge by streamlining the analysis of the gene's vast 65-exon coding region, directly improving clinical mutation detection. Beyond this foundational work, Gervin has made significant contributions to the field of epigenetics, investigating how DNA methylation patterns are established and how they influence complex traits and disease risk. Her research has been instrumental in understanding the dynamics of the human epigenome across the lifespan, with her studies on epigenetic aging and its determinants being particularly influential. Through her rigorous, method-driven approach, Kristina Gervin has provided critical tools and insights that bridge molecular genetics and clinical application, solidifying her reputation as a key figure in modern genomic medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Rapid and Efficient <i>FBN1</i> Mutation Detection Using Automated Sample Preparation and Direct Sequencing As the Primary Strategy
20 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Oslo University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago